CMS extends Appropriate Use Criteria testing period until 2022
![cms-nh-work-for-medicaid](/sites/default/files/styles/900x400/public/2018-06/cms-nh-work-for-medicaid.jpg?itok=1WXYKor3)
The Centers for Medicare & Medicaid Services today announced the extension of its Appropriate Use Criteria testing period through 2021.
This means the AUC program will not impact claims for diagnostic imaging services until Jan. 1, 2022, at the earliest.
The AHA has long advocated for an extension, including most recently in an AHA and American Medical Association joint letter in July. The letter stressed how the COVID-19 public health emergency has resulted in reduced imaging services, adding financial strains and prohibiting providers from sufficiently engaging in the AUC program’s preparatory steps; therefore, AHA is pleased to see CMS implement a delay to this program.
Related News Articles
Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…
Headline
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…